In the past 52-week period, shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) have moved within the range of $95.63 to $133.49. On the stock’s most recent trading day, the company’s shares ended the regular session at $121.62, which is 8.89% lower than its 52-week high.
Zimmer Biomet Holdings, Inc. (ZBH) has demonstrated a 20-day simple moving average (SMA) of 1.24%, and a 50-day SMA of 4.00%. This public company’s current market capitalization stands at $23.91 billion.
Analyzing Consensus Estimates, Sales Revenue and Net Income
When considering entering a position, it is crucial to understand the average enthusiasm level expressed by Wall Street analysts for that particular stock. According to the latest data, the consensus recommendation for Zimmer Biomet Holdings, Inc. (ZBH) is Outperform.
Publicly-traded organizations typically post revenue and earnings results that fall either above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Jun. 2017, Zimmer Biomet Holdings, Inc. (ZBH) delivered a 0.11% surprise with its net revenue. Sales reached $1.95 billion during the three-month period, compared to the average analyst estimate of $1.95 billion.
Meanwhile, during the same quarter Zimmer Biomet Holdings, Inc. (ZBH) delivered a 0.77% earnings surprise. Net earnings for the quarter were posted at $2.08 per share, whereas Wall Street had forecast $2.10 per share.
Ownership at Zimmer Biomet Holdings, Inc. (ZBH), According to Most Recent SEC Filings
We can find critical insight by examining institutional ownership, which are reported in public companies’ most recent 13F filings. Zimmer Biomet Holdings, Inc. (ZBH) has 0.2 billion shares outstanding currently, 87.13% of which belong to institutional investors. Those institutional holdings amount to $21.38 billion.
Additionally, according to the most recent 13F filing from Zimmer Biomet Holdings, Inc. (ZBH), there were 64 new positions totaling 5,944,623 shares of the company’s stock. There were 59 sold out positions, on the other hand, totaling 937,869 shares.
Short, Medium and Long Term Indicators
A stock’s average trade volume, as recorder over the short, medium and long terms, is helpful to analyze in order to gain a better understanding of trading activity and investor sentiment. Zimmer Biomet Holdings, Inc. (ZBH) has had a 20-day average volume of 1,170,810 shares, with an average of 60% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 1,169,772 shares, with an average of 50% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 1,344,706 shares with 33% of long-term indicators pointing to Buy.